Agilent at Metabolomics 2025

We are looking forward to welcoming you to the Metabolomics Society Conference in Prague!

Join us at Booth #P2 to hear about the latest innovative solutions to address the challenges of metabolic research. 

Our experts will be available to discuss:

• End-to-end metabolomics solutions
• High-resolution MS for metabolomics analysis
• Cell analysis solutions to study metabolism
• Software solutions for metabolomics studies

Key Highlights

• Groundbreaking Science: Engage with world-renowned experts who will delve into the latest research on metabolomics in health, disease, plants, food, environment, microbes, and more. Beyond the main topics, the conference will focus on the role of metabolomics in the basic biological research.
• Innovative Technologies: Discover the latest tools and techniques that are revolutionizing the field of metabolomics.
• Global Networking: Connect with a diverse community of scientists, researchers, and industry leaders from around the world.
• Cultural Experiences: Explore the historic beauty of Prague, a city steeped in culture and history

Agilent Lunch Seminar

Join us on Thursday 26 June at 12:25 to 1:25 pm, South Hall 2, to learn how to take your metabolomics workflow to the next level.

A Comprehensive Suite of Next Generation Metabolomics Tools, enabling insights in 3D.

• Dan Cuthbertson, Director, Global Life Science Research Market at Agilent

Combining cellular analysis with mass spectrometry tools yield provide deeper mechanistic insights into drug discovery and metabolomics studies by unlocking data that mass spectrometry cannot provide alone. New developments from Agilent enable these synergies in 3D model systems providing even more powerful insights.

Investigating the Influence of PFAS on Cellular Metabolism in HeLa and HepG2 Cell Lines Using Seahorse Real-Time Cell Metabolic Analysis and Mass Spectrometry Techniques

• David Beale, Senior Research Scientist , Adjunct Professor of RMIT University

This study investigates the metabolic and lipidomic disruptions in HeLa and HepG2 cell lines exposed to PFAS and regulatory concentrations used in drinking water and at higher concentrations typically used in toxicology studies. Using the Agilent Seahorse Real-Time Cell Metabolic Analyser coupled with Mass Spectrometry techniques, we observed significant alterations in cellular energy metabolism and biochemical pathways and differential response based on cell lines.

Agilent Vendor Session

Join us on on Tuesday, June 24 from 3:30, at the Congress Hall.

The New Agilent Seahorse XF Flex Analyzer Takes Real Time Metabolic Analysis to the Third Dimension

• Sofia Vikstrom. Field Application Scientist Manager

The new Agilent Seahorse XF Flex 24-well platform is redefining what’s possible in functional metabolic analysis, empowering researchers to explore metabolism across a broader range of model systems than ever before. From traditional 2D cell cultures to cutting-edge 3D organoids, spheroids, and tissue models, this advanced platform delivers a more physiologically relevant view of metabolism in disease. By bridging the gap between in vitro research and real-world biology, the Seahorse XF Flex enhances research translatability, unlocking deeper insights into cellular function and disease mechanisms.

Agilent Posters

• Agilent’s end-to-end solutions help you take your metabolomics workflows to the next level
  • Daniel Cuthbertson. Agilent Technologies, Santa Clara, US
• A workflow for simultaneous quantitation and discovery analysis using Revident LC-QTOF to follow CRISPRi knockdowns in E. coli metabolism
  • Anna Walke(1),*, Stefan Schäbler (1), Karen E. Yannell (2), Daniel Cuthbertson (2) 
    • (1) Agilent Technologies, Waldbronn, Germany; (2) Agilent Technologies, Santa Clara, US
• Improved drug metabolite identification with a streamlined software workflow
  • Mark Sartain(1), Martin Andre Hoffmann(2), Lee Bertram(1), Andrew McEachran(1), James S. Pyke(1)
    • (1) Agilent Technologies, Inc., Santa Clara, CA, USA; (2)Bright Giant GmbH, Jena, Germany
• Quantification of underivatized acylcarnitines and carnitine intermediates using RP chromatography and ion funnel triple quadrupole in fecal samples
  • Bianca Silva(1), Ruben J. F. Ramos(2), Justin Cross, Karen Yannell(1), Daniel Cuthbertson(1)
    • (1) Agilent Technologies (2)Cell Metabolism Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY
• Discovery workflows: is hi-res always necessary?
  • Hannah Florance, Karen Yannell, Cate Zimmermaker, Genevieve C. Van de Bittner , Mark Sartain, Daniel Cuthbertson, Agilent Technologies